查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790480

美國止血瓣膜市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國止血瓣市場規模及趨勢：

預計 2024 年美國止血瓣市場規模為 6,447 萬美元，2025 年至 2033 年複合年成長率為 5.4%。

心血管疾病盛行率上升、監管支持力度加大、人口老化加劇以及技術持續進步等諸多關鍵因素推動了市場顯著成長。其中一個顯著的促進因素是人們對微創手術的日益偏好，微創手術相較於傳統開放性手術具有諸多優勢，例如疼痛減輕、住院時間縮短、恢復速度更快以及併發症風險更低。

這種轉變刺激了對支持這些手術的醫療設備的需求。止血閥在微創導管手術中發揮著至關重要的作用，它能夠確保血流可控，並防止手術過程中滲漏。

空氣污染日益被認為是導致心血管疾病增加的主要原因。 《2024年世界心臟報告》強調，空氣污染會加劇所有主要心血管疾病（CVD）。 2019年，在與環境空氣污染相關的420萬例死亡中，近70%是由心血管疾病引起的，尤其是缺血性心臟疾病（190萬人死亡）和中風（90萬人死亡）。因此，對血管造影術和血管成形術等診斷和治療程序的需求日益增加，而止血瓣膜在導管介入治療期間透過調節血流，在維護患者安全方面發揮關鍵作用。

醫療設備的技術進步是市場成長的關鍵驅動力。持續的技術進步在提高止血瓣膜的性能和可靠性方面發揮關鍵作用。製造商不斷創新，以改進瓣膜設計、材料品質以及與各種導管尺寸和介入工具的兼容性。這些改善有助於降低漏血風險，提高臨床醫師的易用性，並增強微創手術期間的病人安全性。例如，Merit Medical Systems 提供先進的止血瓣膜，例如 Merit AccessPLUS 和 Honor 止血瓣膜，它們具有人體工學設計、卓越的密封機制和強大的止血控制。這些技術創新體現了業界對最佳化手術效率和減少導管介入手術併發症的關注。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國止血瓣膜市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國止血瓣膜市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國止血閥市場：按類型估計和趨勢分析

  • 美國止血閥市場：類型儀表板
  • 美國止血瓣膜市場：類型變化分析
  • 美國止血閥市場（按類型和銷售）
  • 止血閥Y型接頭
  • 雙Y型接頭止血閥
  • 單手止血閥
  • 其他

第5章美國止血閥市場：應用評估與趨勢分析

  • 美國止血閥市場：應用儀表板
  • 美國止血閥市場：應用變化分析
  • 美國止血閥市場（按應用和銷售）
  • 血管造影術
  • 血管成形術
    • 2021年至2033年的市場估計與預測

第6章美國止血瓣市場：最終用途估計與趨勢分析

  • 美國止血閥市場：最終用途儀表板
  • 美國止血瓣膜市場：最終用途差異分析
  • 美國止血閥市場的應用與銷售情況
  • 醫院
  • 門診手術中心
  • 其他

第7章 競爭態勢

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key company market share analysis, 2024
  • 公司簡介
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun
    • Terumo Corporation
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • DeRoyal Industries, Inc.
    • Antmed Corporation
Product Code: GVR-4-68040-662-4

U.S. Hemostasis Valve Market Size & Trends:

The U.S. hemostasis valve market size was estimated at USD 64.47 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2033.The market is experiencing significant growth due to several key factors, including the rising incidence of cardiovascular diseases, favorable regulatory support, an aging population, and ongoing technological advancements. A notable driver is the increasing preference for minimally invasive procedures, which offer advantages such as less pain, shorter hospital stays, quicker recovery, and a reduced risk of complications compared to traditional open surgeries.

This shift is fueling the demand for medical devices that support these techniques. Hemostasis valves play a critical role in minimally invasive catheter-based procedures by ensuring controlled blood flow and preventing leakage during interventions.

Air pollution is increasingly recognized as a major contributor to the rise in cardiovascular diseases. Both chronic and short-term exposures significantly raise the risk of cardiovascular emergencies and mortality in the U.S. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischemic heart disease (1.9 million deaths) and stroke (900,000 deaths). As a result, there is an increased need for diagnostic and therapeutic procedures such as angiography and angioplasty, where hemostasis valves play a crucial role in maintaining patient safety by regulating blood flow during catheter-based interventions.

Technological advancements in medical devices are pivotal in driving the market growth. Ongoing technological advancements are playing a key role in improving the performance and reliability of hemostasis valves. Manufacturers are continuously innovating to enhance valve design, material quality, and compatibility with a variety of catheter sizes and interventional tools. These improvements help reduce the risk of blood leakage, improve ease of use for clinicians, and enhance patient safety during minimally invasive procedures. For example, Merit Medical Systems offers advanced hemostasis valves such as the Merit AccessPLUS and Honor Hemostasis Valves, which are designed with ergonomic features, superior sealing mechanisms, and robust hemostatic control. These innovations reflect the industry's focus on optimizing procedural efficiency and reducing complications in catheter-based interventions.

U.S. Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hemostasis Valve Y- Connectors
  • Double Y- Y-Connector Hemostasis Valves
  • One-Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Angiography
  • Angioplasty
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Volume price analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hemostasis Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of coronary artery disease (CAD)
      • 3.2.1.2. Advancements in technologies
      • 3.2.1.3. Shift towards minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Product recalls
      • 3.2.2.2. Clinical complexity and procedural risks
  • 3.3. U.S. Hemostasis Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. U.S. Hemostasis Valve Market: Type Dashboard
  • 4.2. U.S. Hemostasis Valve Market: Type Movement Analysis
  • 4.3. U.S. Hemostasis Valve Market by Type, Revenue
  • 4.4. Hemostasis Valve Y-Connectors
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Double Y-Connector Hemostasis Valves
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. One-Handed Hemostasis Valves
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. U.S. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Hemostasis Valve Market: Application Dashboard
  • 5.2. U.S. Hemostasis Valve Market: Application Movement Analysis
  • 5.3. U.S. Hemostasis Valve Market by Application, Revenue
  • 5.4. Angiography
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Angioplasty
    • 5.5.1. Market estimates and forecast 2021to 2033 (USD Million)

Chapter 6. U.S. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. U.S. Hemostasis Valve Market: End Use Dashboard
  • 6.2. U.S. Hemostasis Valve Market: End Use Movement Analysis
  • 6.3. U.S. Hemostasis Valve Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Teleflex Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Merit Medical Systems
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. B. Braun
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Terumo Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Abbott
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Argon Medical Devices
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Freudenberg Medical
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. DeRoyal Industries, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Antmed Corporation
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of secondary sources
  • Table 3 U.S. Hemostasis Valve market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. Hemostasis Valve market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Hemostasis Valve market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 9 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new services
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. Hemostasis Valve market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 U.S. Hemostasis Valve market: Type Outlook Key Takeaways
  • Fig. 14 U.S. Hemostasis Valve market: Type Movement Analysis
  • Fig. 15 Hemostasis Valve Y-Connectors market, 2018 - 2030 (USD Million)
  • Fig. 16 Double Y-Connector Hemostasis Valves market, 2018 - 2030 (USD Million)
  • Fig. 17 One-Handed Hemostasis Valves market, 2018 - 2030 (USD Million)
  • Fig. 18 Others market, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Hemostasis Valve market: Application outlook key takeaways
  • Fig. 20 U.S. Hemostasis Valve market: Application movement analysis
  • Fig. 21 Angiography market, 2018 - 2030 (USD Million)
  • Fig. 22 Angioplasty market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Hemostasis Valve market: End Use outlook key takeaways
  • Fig. 24 U.S. Hemostasis Valve market: End Use movement analysis
  • Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Strategy framework